billS4873Event Tuesday, June 23, 2026Analyzed

A bill to amend the Foreign Assistance Act of 1961 by limiting nonmilitary foreign assistance to organizations that provide or promote abortion, promote gender ideology, or promote discriminatory equity ideology, and for other purposes.

Neutral

Summary

S4873 is a bill to restrict nonmilitary foreign assistance to organizations involved in abortion, gender ideology, or discriminatory equity ideology. It was introduced and referred to committee on June 23, 2026, with no further action or explicit funding provisions. As an early-stage authorization bill with no direct market mechanism, its near-term financial impact on any sector is negligible.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.S4873 is a procedural, early-stage bill with no funding or market mechanism.
  • 2.No publicly traded company has a causal chain to this bill's provisions.
  • 3.Near-term market impact is zero; monitoring required only if committee action accelerates.

Market Implications

No market impact arises from this bill. Defense sector tickers (BA, BAH, GD, HII, LDOS, LHX, LMT, NOC, RTX) are unaffected because military foreign assistance is explicitly excluded. No other sector is affected. Investors should ignore this bill unless it progresses to committee markup, which would signal potential for indirect effects on global health funding flows — but even then, no public company is directly tied.

Full Analysis

This bill (S4873) was introduced in the Senate on June 23, 2026, by Senator Budd (R-NC) and referred to the Committee on Foreign Relations. It aims to amend the Foreign Assistance Act of 1961 by limiting nonmilitary foreign assistance to organizations that provide or promote abortion, promote gender ideology, or promote discriminatory equity ideology. The bill is in its earliest legislative stage with only two actions: introduction and referral to committee. There is no companion bill, no committee markup, and no funding authorized or appropriated. The mechanism of the bill is a policy restriction on foreign aid eligibility, not a direct market intervention.

The money trail is absent — this bill does not authorize or appropriate any funds. It changes which organizations can receive existing foreign assistance but does not create new spending or contract opportunities for any U.S. companies. The affected sector would be healthcare nonprofits and global health NGOs, but these are not publicly traded entities in a way that maps to stock tickers with any confidence. No ticker from the provided Defense sector data has any causal link to this bill; defense contractors receive military foreign assistance (FMF) explicitly exempted from this bill's restrictions.

There is no convergence with other government signals in the provided context. The bill is an isolated, early-stage legislative effort with no procurement, executive action, or related bills to amplify its market impact.

Structural winners and losers are not identifiable at this stage. The bill does not create revenue or cost impacts for any publicly traded company. Its path to enactment is long — it must pass the Senate Foreign Relations Committee, the full Senate, the House, and be signed by The President before any effect takes place. Current status suggests minimal momentum.

Key Legislators

Sen. Budd, Ted [R-NC]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →